+499.5%
MRNA vs PFGC
-5.1%
+504.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | PFGC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.5% | -1.7% | -2.3% |
| 7D | +5.5% | -2.2% | +7.7% | +5.1% |
| 30D | +158.7% | -11.9% | +170.7% | +158.0% |
| 3M | +182.1% | +5.0% | +177.1% | +176.0% |
| 6M | +151.8% | +8.6% | +143.2% | +143.1% |
| YTD | +393.6% | +9.7% | +383.9% | +383.1% |
| 1Y | +499.5% | -6.3% | +505.8% | +489.4% |
| All | +499.5% | -5.1% | +504.6% | +489.4% |
Cumulative growth
Daily Returns
Daily percentage return beside PFGC.
Daily Out/Under-Performance
Portfolio return minus PFGC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PFGC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded PFGC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling